All posts by Karen Hermanson

Celdara Medical and ARMI Partner to Accelerate Commercialization of Regional Biofabrication Technologies  Lebanon, NH: Celdara Medical today announced a partnership with the Advanced Regenerative Manufacturing Institute (ARMI) to support and advise ARMI’s newly-created BioFab Startup Lab and its portfolio companies.  The BioFab Startup Lab includes companies that are developing medical […]

Lebanon, NH: Celdara Medical is pleased to congratulate one of its Scientific Founders, Dr. Charles Sentman, on his recent selection as a 2022 National Academy of Inventors (NAI) Fellow. The NAI Fellows Program honors academic inventors who have demonstrated a prolific spirit of innovation in creating inventions with tangible impact […]

Lebanon, NH: Celdara Medical, LLC today announced Dr. Jonathan Heller as its first Entrepreneur in Residence (EIR). Celdara Medical is developing a diverse portfolio of preclinical therapeutic assets, platforms, and companies. Heller is primarily responsible for advancing one of Celdara’s lead therapeutic programs to spin-out or exit.    “Celdara’s pipeline […]

Celdara Medical Receives Funding to Develop Broad-Spectrum Antimicrobials for Chronic Lung Infection     Lebanon, NH: The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has awarded Celdara Medical, LLC a Phase I Small Business Innovation Research (SBIR) grant for development of broad-spectrum antimicrobial peptides […]

Lebanon, NH: Celdara Medical, LLC announced today that the National Cancer Institute (NCI) of the National Institutes of Health (NIH) has awarded a Phase II Small Business Innovation Research (SBIR) Fast-Track grant to fund company’s ongoing development of CM-CX1, a chimeric antigen receptor (CAR) T cell therapy for the treatment […]

Press Release Celdara Medical, LLC today announced that the National Cancer Institute of the National Institutes of Health (NIH) has awarded a Small Business Innovation Research (SBIR) Phase I award to fund the company’s proof of concept studies on a new platform to improve chimeric antigen receptor (CAR) T cells […]